Where Medical Affairs may have served in a scientific support role in years past, now it is one of the key drivers of all efforts, positioned at the nexus of Regulatory, Clinical, Market Access, and Commercial needs, as a bridge to all and as a strategic partner with Commercial. This has occurred in large part because the days of successfully launching a new product based solely on making it available through regulatory approval and marketing efforts no longer exists. Use the MAPS Launch Excellence Standards & Guidance plus templates to guide your launch planning process in this new Medical Affairs landscape.
Authors
Ramin Farhood, PharmD, MBA
Vice President, Head of Global Medical Affairs, AveXis
Medical Affairs Professional Society
Greg Keenan, MD
Former Vice President, Medical Affairs and US Head Medical Officer, AstraZeneca
Medical Affairs Professional Society
Tricia L. Gooljarsingh, PhD, CMPP
Senior Director, Ironwood Pharmaceuticals
Medical Affairs Professional Society
Meg Heim, RN, MAS
Vice President, Head of North America DCV Scientific Communications, NA DCV Medical Affairs, Sanofi
Medical Affairs Professional Society
Lobna Salem, MD, MBA
Chief Medical Officer, Developed Markets, Upjohn Pfizer
Medical Affairs Professional Society
Paul Tebbey, PhD, MBA
Therapeutic Area Head, US Oncology Medical Affairs, AbbVie